Experimental	experimental	O	O	O	O
cyclosporine	cyclosporine	CHEMICALS	O	OTHERS	I
nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
:	:	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
concomitant	concomitant	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
cyclosporine	cyclosporine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
CSA	csa	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
alone	alone	O	O	O	O
or	or	O	O	O	O
in	in	O	O	O	O
combination	combination	O	O	O	O
with	with	O	O	O	O
various	various	O	O	O	O
chemotherapeutics	chemotherapeutics	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
development	development	O	O	O	O
of	of	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
was	was	O	O	O	O
evaluated	evaluated	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

Administration	administration	O	O	O	O
of	of	O	O	O	O
20	20	O	O	O	O
mg/kg/day	mg/kg/day	O	O	O	O
CSA	csa	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
4	4	O	O	O	O
weeks	weeks	O	O	O	O
caused	caused	O	O	O	O
renal	renal	O	O	O	O
functional	functional	O	O	O	O
and	and	O	O	O	O
structural	structural	O	O	O	O
changes	changes	O	O	O	O
similar	similar	O	O	O	O
to	to	O	O	O	O
those	those	O	O	O	O
reported	reported	O	O	O	O
in	in	O	O	O	O
man	man	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
combined	combined	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
CSA	csa	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
various	various	O	O	O	O
chemotherapeutic	chemotherapeutic	O	O	O	O
drugs	drugs	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
nephrotoxic	nephrotoxic	O	DISEASE	OTHERS	I
potential	potential	O	O	O	O
,	,	O	O	O	O
such	such	O	O	O	O
as	as	O	O	O	O
gentamicin	gentamicin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
at	at	O	O	O	O
therapeutic	therapeutic	O	O	O	O
doses	doses	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
amphothericin	amphothericin	O	O	OTHERS	I
B	b	O	O	OTHERS	I
and	and	O	O	O	O
ketoconazole	ketoconazole	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
are	are	O	O	O	O
frequently	frequently	O	O	O	O
used	used	O	O	O	O
in	in	O	O	O	O
immunosuppressed	immunosuppressed	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
aggravate	aggravate	O	O	O	O
the	the	O	O	O	O
CSA	csa	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
rat	rat	O	O	O	O
model	model	O	O	O	O
.	.	O	O	O	O

Gentamicin	gentamicin	CHEMICALS	O	OTHERS	I
at	at	O	O	O	O
toxic	toxic	O	O	O	O
doses	doses	O	O	O	O
,	,	O	O	O	O
however	however	O	O	O	O
,	,	O	O	O	O
increased	increased	O	O	O	O
CSA	csa	CHEMICALS	O	OTHERS	I
nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Thus	thus	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
CSA	csa	CHEMICALS	O	OTHERS	I
has	has	O	O	O	O
a	a	O	O	O	O
different	different	O	O	O	O
pathogenetic	pathogenetic	O	O	O	O
mechanism	mechanism	O	O	O	O
.	.	O	O	O	O

